IRIS Accounts Production v23.3.1.45 06304797 Board of Directors 1.8.22 31.7.23 31.7.23 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh063047972022-07-31063047972023-07-31063047972022-08-012023-07-31063047972021-07-31063047972021-08-012022-07-31063047972022-07-3106304797ns10:Originalns15:EnglandWales2022-08-012023-07-3106304797ns14:PoundSterlingns10:Original2022-08-012023-07-3106304797ns10:Originalns10:Director12022-08-012023-07-3106304797ns10:Original2022-08-012023-07-3106304797ns10:Original2023-07-3106304797ns10:Originalns10:PrivateLimitedCompanyLtd2022-08-012023-07-3106304797ns10:Originalns10:SmallEntities2022-08-012023-07-3106304797ns10:Originalns10:AuditExempt-NoAccountantsReport2022-08-012023-07-3106304797ns10:Originalns10:SmallCompaniesRegimeForDirectorsReport2022-08-012023-07-3106304797ns10:SmallCompaniesRegimeForAccountsns10:Original2022-08-012023-07-3106304797ns10:Originalns10:FullAccounts2022-08-012023-07-3106304797ns10:Originalns10:Director22022-08-012023-07-3106304797ns10:Originalns10:Director32022-08-012023-07-3106304797ns10:Originalns10:Director42022-08-012023-07-3106304797ns10:Originalns10:Director52022-08-012023-07-3106304797ns10:Originalns10:Director62022-08-012023-07-3106304797ns10:Originalns10:Director72022-08-012023-07-3106304797ns10:Director8ns10:Original2022-08-012023-07-3106304797ns10:Originalns10:Director92022-08-012023-07-3106304797ns10:CompanySecretary1ns10:Original2022-08-012023-07-3106304797ns10:Originalns10:CompanySecretary22022-08-012023-07-3106304797ns10:Originalns10:RegisteredOffice2022-08-012023-07-3106304797ns10:Original2022-07-3106304797ns10:Originalns5:CurrentFinancialInstruments2023-07-3106304797ns10:Originalns5:CurrentFinancialInstruments2022-07-3106304797ns10:Originalns5:Non-currentFinancialInstruments2023-07-3106304797ns10:Originalns5:Non-currentFinancialInstruments2022-07-3106304797ns5:ShareCapitalns10:Original2023-07-3106304797ns5:ShareCapitalns10:Original2022-07-3106304797ns10:Originalns5:RetainedEarningsAccumulatedLosses2023-07-3106304797ns10:Originalns5:RetainedEarningsAccumulatedLosses2022-07-3106304797ns10:Originalns5:OwnedOrFreeholdAssetsns5:LandBuildings2022-08-012023-07-3106304797ns10:Original2021-08-012022-07-3106304797ns10:Originalns5:LandBuildings2022-07-3106304797ns10:Originalns5:LandBuildings2023-07-3106304797ns10:Originalns5:LandBuildings2022-07-3106304797ns10:Originalns5:CostValuation2022-07-3106304797ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2023-07-3106304797ns10:Originalns5:Non-currentFinancialInstrumentsns5:MoreThanFiveYears2022-07-31
REGISTERED NUMBER: 06304797 (England and Wales)















Unaudited Financial Statements for the Year Ended 31 July 2023

for

Edgemont Healthcare Limited

Edgemont Healthcare Limited (Registered number: 06304797)






Contents of the Financial Statements
for the Year Ended 31 July 2023




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 4


Edgemont Healthcare Limited

Company Information
for the Year Ended 31 July 2023







DIRECTORS: Dr S Illingworth
Dr B Whiteside
Dr D Bailey
Dr P Taylor
Dr M Bigwood
Dr S Lowrey
Dr H A Aderogba
Mrs C McCarthy
Branchy Trading Limited





SECRETARIES: Mrs C McCarthy
Branchy Trading Limited





REGISTERED OFFICE: Dayan House
818 Whitchurch Lane
Whitchurch
Bristol
BS14 0JP





REGISTERED NUMBER: 06304797 (England and Wales)






Edgemont Healthcare Limited (Registered number: 06304797)

Balance Sheet
31 July 2023

31.7.23 31.7.22
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 988,840 988,840
Investments 5 200 200
989,040 989,040

CURRENT ASSETS
Debtors 6 359,800 684,800
Cash at bank 1,388 16,358
361,188 701,158
CREDITORS
Amounts falling due within one year 7 184,310 446,750
NET CURRENT ASSETS 176,878 254,408
TOTAL ASSETS LESS CURRENT
LIABILITIES

1,165,918

1,243,448

CREDITORS
Amounts falling due after more than
one year

8

746,766

855,063
NET ASSETS 419,152 388,385

CAPITAL AND RESERVES
Called up share capital 1,000 1,000
Retained earnings 418,152 387,385
SHAREHOLDERS' FUNDS 419,152 388,385

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2023.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2023 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

Edgemont Healthcare Limited (Registered number: 06304797)

Balance Sheet - continued
31 July 2023


The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 23 September 2023 and were signed on its behalf by:





Branchy Trading Limited - Director


Edgemont Healthcare Limited (Registered number: 06304797)

Notes to the Financial Statements
for the Year Ended 31 July 2023

1. STATUTORY INFORMATION

Edgemont Healthcare Limited is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.
Freehold property - in accordance with the property

Investments in subsidiaries
Investments in subsidiary undertakings are recognised at cost.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Edgemont Healthcare Limited (Registered number: 06304797)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 2 (2022 - 2 ) .

4. TANGIBLE FIXED ASSETS
Freehold
property
£   
COST
At 1 August 2022
and 31 July 2023 988,840
NET BOOK VALUE
At 31 July 2023 988,840
At 31 July 2022 988,840

5. FIXED ASSET INVESTMENTS
Shares in
group
undertaking
£   
COST
At 1 August 2022
and 31 July 2023 200
NET BOOK VALUE
At 31 July 2023 200
At 31 July 2022 200

6. DEBTORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.7.23 31.7.22
£    £   
Amounts owed by group undertakings 359,800 684,800

Edgemont Healthcare Limited (Registered number: 06304797)

Notes to the Financial Statements - continued
for the Year Ended 31 July 2023

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.7.23 31.7.22
£    £   
Trade creditors 199 612
Amounts owed to group undertakings 2,036 267,036
Tax 7,905 4,932
Social security and other taxes 300 300
Directors' current accounts 152,100 152,100
Accruals and deferred income 21,770 21,770
184,310 446,750

8. CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR
31.7.23 31.7.22
£    £   
Bank loans more 5 yrs non-inst 746,766 855,063

Amounts falling due in more than five years:

Repayable otherwise than by instalments
Bank loans more 5 yrs non-inst 746,766 855,063